title: Exercise and variations in neuropeptide concentrations in rheumatoid arthritis.
abstract: The aim of the present study was to investigate the influence of an exercise program on neuropeptide concentrations, disease activity, impairments and disabilities in rheumatoid arthritis (RA). Eleven females (median age 60 years, median disease duration 6.5 years, ARA functional classes I or II) exercised 30 min daily for 4 weeks. The urine concentrations of calcitonin gene-related peptide-like immunoreactivity (CGRP-LI) and neuropeptide Y-like immunoreactivity (NPY-LI) were analyzed 1 week prior to exercise start, at exercise start, after 2 and 4 weeks of exercise, and after a 4-week follow-up period. Measurements of disease activity, aerobic capacity, grip force, limb muscle function, and activities of daily living (ADL) were also undertaken. The results indicate a decrease (md 5.64 pM to md 3.48 pM, P</=0.05) of CGRP-LI concentrations after 4 weeks' exercise. NPY-LI concentrations remained unchanged, as did disease activity and aerobic capacity. Muscle function and ADL capacity improved significantly (P</=0.05) after the exercise period. Only the improved grip force remained after the follow-up period. In conclusion the results indicate that decreased CGRP-LI concentration, probably reflecting a decreased sympathetic tone, follows physical exercise and suggest that regular physical activity might be important among individuals with RA to maintain a decreased sympathetic tone and less symptoms from their disease.
authors.affiliation: Department of Rheumatology, Karolinska Hospital, Stockholm, Sweden. stenstrom@ebox.tninet.se
authors.forename: C H
authors.initials: CH
authors.lastname: Stenström
authors.forename: H
authors.initials: H
authors.lastname: Alexanderson
authors.forename: I
authors.initials: I
authors.lastname: Lundberg
authors.forename: T
authors.initials: T
authors.lastname: Lundeberg
authors.forename: E
authors.initials: E
authors.lastname: Theodorsson
authors.forename: R
authors.initials: R
authors.lastname: Nisell
mesh_terms: D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000534:rehabilitation / Q000628:therapy / Q000652:urine*; D015740:Calcitonin Gene-Related Peptide / Q000652:urine*; D004185:Disability Evaluation; D015444:Exercise / Q000502:physiology*; D005081:Exercise Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000502:physiology; D009478:Neuropeptide Y / Q000652:urine*; D010865:Pilot Projects
chemical_list: D009478:Neuropeptide Y; D015740:Calcitonin Gene-Related Peptide